Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Locke

Showing results (71-80 of 234) with videos related to

Pageof 24
Sort By:
Ejhaem|July 18, 2022
Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphomaSemira Sheikh, Sepideh Mokhtari, Jeffrey A Silverman, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center ExperienceMohamed A Kharfan-Dabaja, Ambuj Kumar, Facundo E Stingo, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Frontiers in Oncology|December 11, 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacyYoganand Balagurunathan, Zhouping Wei, Jin Qi, et al.
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host DiseaseChiara Frairia, Maura Nicolosi, Jamie Shapiro, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron A Jacobson, Jason R Westin, David B Miklos, et al.
Pageof 24

Showing results (71-80 of 234) with videos related to

Sort By:
Pageof 24
Ejhaem|July 18, 2022
Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphomaSemira Sheikh, Sepideh Mokhtari, Jeffrey A Silverman, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Richter Syndrome: A Single-Center ExperienceMohamed A Kharfan-Dabaja, Ambuj Kumar, Facundo E Stingo, et al.
Blood Advances|May 1, 2023
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphomaErin A Dean, Gregory J Kimmel, Matthew J Frank, et al.
Frontiers in Oncology|December 11, 2024
Radiomic features of PET/CT imaging of large B cell lymphoma lesions predicts CAR T cell therapy efficacyYoganand Balagurunathan, Zhouping Wei, Jin Qi, et al.
Transplantation and Cellular Therapy|June 2, 2021
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell LymphomaAlbert Cortes-Bullich, Ariel Perez, Christina Bachmeier, et al.
Nature Reviews. Clinical Oncology|February 14, 2018
Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'Sattva S Neelapu, Sudhakar Tummala, Partow Kebriaei, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2020
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host DiseaseChiara Frairia, Maura Nicolosi, Jamie Shapiro, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Blood Neoplasia|January 15, 2026
Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasJulio C Chavez, Ellen Napier, Attilio Bondanza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Axicabtagene Ciloleucel in Combination With Atezolizumab in Patients With Refractory Diffuse Large B-cell Lymphoma: The Phase 1/2 ZUMA-6 TrialCaron A Jacobson, Jason R Westin, David B Miklos, et al.
Pageof 24